Clinician-rated functioning and patient-rated quality of life in schizophrenia: Implications of their correspondence for psychopathology and side effects

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 1, 2010, Pages 225-230

  Jung, Hee Yeon ^a   Hwang, Samuel Suk Hyun ^a,b   Yi, Jung Seo ^c   Kim, Yeni ^a,d   Kim, Yong Sik ^a,d  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Hallym University College of Medicine   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

General functioning; Quality of life; Schizophrenia; Subjective life satisfaction; Subjective side effects

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; FEMALE; HOSPITAL PATIENT; HOSTILITY; HUMAN; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; OUTPATIENT; PARANOIA; PATIENT ATTITUDE; PHOBIA; PHYSICIAN ATTITUDE; POSITIVE SYNDROME; PSYCHOSIS; QUALITY OF LIFE; SCHIZOPHRENIA; SELF REPORT; SOMATIZATION;

ADULT; ANALYSIS OF VARIANCE; CONFIDENCE INTERVALS; FEMALE; HUMANS; MALE; PATIENT SATISFACTION; PERSONALITY INVENTORY; PHYSICIANS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOPATHOLOGY; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CONCEPT; YOUNG ADULT;

EID: 73649144172     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.11.012     Document Type: Article

References (61)

1. Aichhorn W., Gasser M., Weiss E.M., Adlassnig C., and Marksteiner J. Gender differences in pharmacokinetics and side effects of second generation antipsychotic drugs. Curr Neuropharm 3 (2005) 73-85
2. Aki H., Tomotake M., Kaneda Y., Iga J., Kinouchi S., Shibuya-Tayoshi S., et al. Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia. Psychiatry Res 158 (2008) 19-25
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC; 2000 [text rev.].
4. Atkinson M.J., and Caldwell L. The differential effects of mood on patients' ratings of life quality and satisfaction with their care. J Affect Disord 44 a (1997) 169-175
5. Atkinson M., Zibin S., and Chuang H. Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am J Psychiatry 154 (1997) 99-105
6. Awad A.G., Voruganti L.N., and Heslegrave R.J. A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation. Qual Life Res 6 (1997) 21-26
7. Bebbington P.E., Angermeyer M., Azorin J.M., Marwaha S., Marteau F., and Toumi M. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia. Acta Psychiatr Scand Suppl (2009) 22-28
8. Bechdolf A., Klosterkotter J., Hambrecht M., Knost B., Kuntermann C., Schiller S., et al. Determinants of subjective quality of life in post acute patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 253 (2003) 228-235
9. Bowie C.R., Twamley E.W., Anderson H., Halpern B., Patterson T.L., and Harvey P.D. Self-assessment of functional status in schizophrenia. J Psychiatr Res 41 (2007) 1012-1018
10. Browne S., Roe M., Lane A., Gervin M., Morris M., Kinsella A., et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 94 (1996) 118-124
11. Burlingame G.M., Dunn T.W., Chen S., Lehman A., Axman R., Earnshaw D., et al. Selection of outcome assessment instruments for inpatients with severe and persistent mental illness. Psychiatr Serv 56 (2005) 444-451
12. Carpiniello B., Lai G.L., Pariante C.M., Carta M.G., and Rudas N. Symptoms, standards of living and subjective quality of life: a comparative study of schizophrenic and depressed out-patients. Acta Psychiatr Scand 96 (1997) 235-241
13. Day J.C., Kinderman P., and Bentall R. A comparison of patients' and prescribers' beliefs about neuroleptic side-effects: prevalence, distress and causation. Acta Psychiatr Scand 97 (1998) 93-97
14. Dernovsek M.Z., Prevolnik Rupel V., Rebolj M., and Tavcar R. Quality of life and treatment costs in schizophrenic outpatients, treated with depot neuroleptics. Eur Psychiatry 16 (2001) 474-482
15. Derogatis L.R. SCL-90(Revised) Manual I (1977), Johns Hopkins University School of Medicine, Baltimore
16. Derogatis L.R., Rickels K., and Rock A.F. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 128 (1976) 280-289
17. Dickerson F.B., Ringel N.B., and Parente F. Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates. Acta Psychiatr Scand 98 (1998) 124-127
18. Eack S.M., and Newhill C.E. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull 33 (2007) 1225-1237
19. Eack S.M., Newhill C.E., Anderson C.M., and Rotondi A.J. Quality of life for persons living with schizophrenia: more than just symptoms. Psychiatr Rehabil J 30 (2007) 219-222
20. Fitzgerald P.B., Williams C.L., Corteling N., Filia S.L., Brewer K., Adams A., et al. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand 103 (2001) 387-392
21. Flyckt L.K., Taube A., Edman G.V., and Jedenius E. An inventory of chronic, mentally disabled schizophrenic outpatients. Schizophr Res 18 (1996) 239
22. Hamer S., and Haddad P.M. Adverse effects of antipsychotics as outcome measures. Br J Psychiatry Suppl 50 (2007) s64-s70
23. Heider D., Angermeyer M.C., Winkler I., Schomerus G., Bebbington P.E., Brugha T., et al. A prospective study of quality of life in schizophrenia in three European countries. Schizophr Res 93 (2007) 194-202
24. Huppert J.D., Weiss K.A., Lim R., Pratt S., and Smith T.E. Quality of life in schizophrenia: contributions of anxiety and depression. Schizophr Res 51 (2001) 171-180
25. Kaiser W., Priebe S., Barr W., Hoffmann K., Isermann M., Röder-Wanner U., et al. Profiles of subjective quality of life in schizophrenic in- and out-patient samples. Psychiatry Res 66 (1997) 153-166
26. Karow A., and Naber D. Subjective well-being and quality of life under atypical antipsychotic treatment. Psychopharmacology (Berl) 162 (2002) 3-10
27. Karow A., Pajonk F.G., Reimer J., Hirdes F., Osterwald C., et al. The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life. Eur Arch Psychiatry Clin Neurosci 258 (2008) 152-159
28. Kasckow J.W., Twamley E., Mulchahey J.J., Carroll B., Sabai M., Strakowski S.M., et al. Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients. Psychiatry Res 103 (2001) 69-78
29. Kim J.H., and Kim K.I. The standardization study of Symptom Checklist-90-Revision in Korea III. Mental Health Res 2 (1984) 278-310
30. Kim J.H., and Yoon Y.H. Reliability and factorial invariance of Korean version of the Symptom Checklist-90-Reivision. Mental Health Res 3 (1985) 166-172
31. Krawiecka M., Goldberg D., and Vaughan M. A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr Scand 55 (1977) 299-308
32. Kugo A., Terada S., Ishizu H., Takeda T., Sato S., Habara T., et al. Quality of life for patients with schizophrenia in a Japanese psychiatric hospital. Psychiatry Res 144 (2006) 49-56
33. Lasalvia A., Ruggeri M., and Santolini N. Subjective quality of life: its relationship with clinician-rated and patient-rated psychopathology - the South-Verona Outcome Project 6. Psychother Psychosom 71 (2002) 275-284
34. Larsen E.B., and Gerlach J. Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics. Acta Psychiatr Scand 93 (1996) 381-388
35. Lehman A.F. The well-being of chronic mental patients: assessing their quality of life. Arch Gen Psychiatry 40 (1983) 369-373
36. Leung A., and Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand 101 (2003) 3-38
37. Lincoln T.M., Lüllmann E., and Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophr Bull 33 6 (2007) 1324-1342
38. Lysaker P.H., Buck K.D., Hammoud K., Taylor A.C., and Roe D. Associations of symptoms, psychosocial function and hope with qualities of self-experience in schizophrenia: comparisons of objective and subjective indicators of health. Schizophr Res 82 (2006) 241-249
39. Manchanda R., Saupe R., and Hirsch S.R. Comparison between the Brief Psychiatric Rating Scale and the Manchester Scale for the rating of schizophrenic symptoms. Acta Psychiatr Scand 74 (1986) 563-568
40. Mechanic D., McAlpine D., Rosenfield S., and Davis D. Effects of illness attribution and depression on the quality of life among persons with serious mental illness. Soc Sci Med 39 (1994) 155-164
41. Melle I., Friis S., Haahr U., Johannesen J.O., Larsen T.K., Opjordsmoen S., et al. Measuring quality of life in first-episode psychosis. Eur Psychiatry 20 (2005) 474-483
42. Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol 10 Suppl 3 (1995) 133-138
43. Naber D., Moritz S., Lambert M., Rajonk F., Holzbach R., Mass R., et al. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res 50 (2001) 79-88
44. Naber D., Riedel M., Klimke A., Vorbach E., Lambert M., Kühn K., et al. Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Acta Psychiatr Scand 111 (2005) 106-115
45. Narvaez J.M., Twamley E.W., McKibbin C.L., Heaton R.K., and Patterson T.L. Subjective and objective quality of life in schizophrenia. Schizophr Res 98 (2008) 201-208
46. Oh K.J., Yum T.H., Park Y.S., Kim C.K., and Lee Y.H. Age-intelligence relationship in adulthood: a cross sectional analysis of K-WAIS standardization data. Korean J Clin Psychology 11 (1992) 22-30
47. Ramirez A., Ekselius L., and Ramklint M. Axis V - Global Assessment of Functioning Scale (GAF), further evaluation of the self-report version. Eur Psychiatry 23 (2008) 575-579
48. Ruggeri M., Bisoffi G., Fontecedro L., and Warner R. Subjective and objective dimensions of quality of life in psychiatric patients: a factor analytical approach: the South Verona Outcome Project 4. Br J Psychiatry 178 (2001) 268-275
49. Söderberg P., Tungström S., and Armelius B.A. Special section on the GAF: reliability of Global Assessment of Functioning ratings made by clinical psychiatric staff. Psychiatr Serv 56 (2005) 434-438
50. Startup M., Jackson M.C., and Bendix S. The concurrent validity of the Global Assessment of Functioning (GAF). Br J Clin Psychol 41 (2002) 417-422
51. Strejilevich S.A., Palatnik A., Avila R., Bustin J., Cassone J., Figueroa S., et al. Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics. Psychiatry Res 133 (2005) 277-280
52. Terada S., Ishizu H., Fujisawa Y., Fujita D., Yokota O., Nakashima H., et al. Development and evaluation of a health-related quality of life questionnaire for the elderly with dementia in Japan. Int J Geriatr Psychiatry 17 (2002) 851-858
53. Voruganti L., Heslegrave R., Awad A.G., and Seeman M.V. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 28 (1998) 165-172
54. Voruganti L., Cortese L., Oyewumi L., Cernovsky Z., Zirul S., and Awad A. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life. Schizophr Res 43 (2000) 135-145
55. Warner R., de Girolamo G., Belelli G., Bologna C., Fioritti A., and Rosini G. The quality of life of people with schizophrenia in Boulder, Colorado, and Bologna, Italy. Schizophr Bull 24 (1998) 559-568
56. Wehmeier P.M., Kluge M., Schneider E., Schacht A., Wagner T., and Schreiber W. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 703-712
57. Yamauchi K., Aki H., Tomotake M., Iga J., Numata S., Motoki I., et al. Predictors of subjective and objective quality of life in outpatients with schizophrenia. Psychiatry Clin Neurosci 62 (2008) 404-411
58. Yang O.K. Development of the Life Satisfaction Rating Scale. Korean J. Social Welfare 24 (1994) 157-198
59. Yassa R., and Jeste D.V. Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 18 (1992) 701-715
60. Yi J.S., Chung M.H., Lee B.W., and Lee S.I. Reliability and validity of the Korean Version of Global Assessment of Functioning Scale. Schizophrenia Clinics 6 (2003) 118-124
61. Zhang P.L., Santos J.M., Newcomer J., Pelfrey B.A., Johnson M.C., and de Erausquin G.A. Impact of atypical antipsychotics on quality of life, self-report of symptom severity, and demand of services in chronically psychotic patients. Schizophr Res 71 (2004) 137-144